249 related articles for article (PubMed ID: 22042945)
1. Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma.
Hodson A; Crichton S; Montoto S; Mir N; Matutes E; Cwynarski K; Kumaran T; Ardeshna KM; Pagliuca A; Taylor GP; Fields PA
J Clin Oncol; 2011 Dec; 29(35):4696-701. PubMed ID: 22042945
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.
Bazarbachi A; Plumelle Y; Carlos Ramos J; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; Panelatti G; Hermine O
J Clin Oncol; 2010 Sep; 28(27):4177-83. PubMed ID: 20585095
[TBL] [Abstract][Full Text] [Related]
3. "Antivirals" in the treatment of adult T cell leukaemia- lymphoma (ATLL).
Fields PA; Taylor GP
Curr Hematol Malig Rep; 2012 Dec; 7(4):267-75. PubMed ID: 23093306
[TBL] [Abstract][Full Text] [Related]
4. Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL).
Ceesay MM; Matutes E; Taylor GP; Fields P; Cavenagh J; Simpson S; Ho A; Devereux S; Mufti GJ; Pagliuca A
Leuk Res; 2012 Jul; 36(7):857-61. PubMed ID: 22209076
[TBL] [Abstract][Full Text] [Related]
5. Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia/lymphoma (ATLL): a systematic review and meta-analysis.
Shafiee A; Seighali N; Taherzadeh-Ghahfarokhi N; Mardi S; Shojaeian S; Shadabi S; Hasani M; Haghi S; Mozhgani SH
Virol J; 2023 Jun; 20(1):118. PubMed ID: 37287047
[TBL] [Abstract][Full Text] [Related]
6. A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma: a multicenter clinicopathologic experience and new prognostic score.
Phillips AA; Shapira I; Willim RD; Sanmugarajah J; Solomon WB; Horwitz SM; Savage DG; Bhagat G; Soff G; Zain JM; Alobeid B; Seshan VE; O'Connor OA
Cancer; 2010 Jul; 116(14):3438-46. PubMed ID: 20564100
[TBL] [Abstract][Full Text] [Related]
7. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.
Gill PS; Harrington W; Kaplan MH; Ribeiro RC; Bennett JM; Liebman HA; Bernstein-Singer M; Espina BM; Cabral L; Allen S
N Engl J Med; 1995 Jun; 332(26):1744-8. PubMed ID: 7760890
[TBL] [Abstract][Full Text] [Related]
8. THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study.
Takamatsu Y; Suzumiya J; Utsunomiya A; Maeda K; Matsuoka H; Suzushima H; Tsukada J; Shibata K; Tamura K;
Eur J Haematol; 2010 May; 84(5):391-7. PubMed ID: 20059527
[TBL] [Abstract][Full Text] [Related]
9. Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa.
Hermine O; Bouscary D; Gessain A; Turlure P; Leblond V; Franck N; Buzyn-Veil A; Rio B; Macintyre E; Dreyfus F
N Engl J Med; 1995 Jun; 332(26):1749-51. PubMed ID: 7760891
[No Abstract] [Full Text] [Related]
10. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.
Hermine O; Allard I; Lévy V; Arnulf B; Gessain A; Bazarbachi A;
Hematol J; 2002; 3(6):276-82. PubMed ID: 12522449
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome.
Tanosaki R; Uike N; Utsunomiya A; Saburi Y; Masuda M; Tomonaga M; Eto T; Hidaka M; Harada M; Choi I; Yamanaka T; Kannagi M; Matsuoka M; Okamura J
Biol Blood Marrow Transplant; 2008 Jun; 14(6):702-8. PubMed ID: 18489996
[TBL] [Abstract][Full Text] [Related]
12. Treatment of adult T-cell leukemia/lymphoma: past, present, and future.
Ishitsuka K; Tamura K
Eur J Haematol; 2008 Mar; 80(3):185-96. PubMed ID: 18081707
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous T-cell lymphoma with HTLV-I infection: clinical overlap with adult T-cell leukemia/lymphoma.
Sakamoto FH; Colleoni GW; Teixeira SP; Yamamoto M; Michalany NS; Almeida FA; Chiba AK; Petri V; Fernandes MA; Pombo-de-Oliveira MS
Int J Dermatol; 2006 Apr; 45(4):447-9. PubMed ID: 16650175
[TBL] [Abstract][Full Text] [Related]
14. Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients.
Matutes E; Taylor GP; Cavenagh J; Pagliuca A; Bareford D; Domingo A; Hamblin M; Kelsey S; Mir N; Reilly JT
Br J Haematol; 2001 Jun; 113(3):779-84. PubMed ID: 11380470
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha.
Mahieux R; Hermine O
Leuk Lymphoma; 2005 Mar; 46(3):347-55. PubMed ID: 15621824
[TBL] [Abstract][Full Text] [Related]
16. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.
Tsukasaki K; Utsunomiya A; Fukuda H; Shibata T; Fukushima T; Takatsuka Y; Ikeda S; Masuda M; Nagoshi H; Ueda R; Tamura K; Sano M; Momita S; Yamaguchi K; Kawano F; Hanada S; Tobinai K; Shimoyama M; Hotta T; Tomonaga M;
J Clin Oncol; 2007 Dec; 25(34):5458-64. PubMed ID: 17968021
[TBL] [Abstract][Full Text] [Related]
17. Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa.
Guery R; Suarez F; Lanternier F; Bougnoux ME; Lecuyer H; Avettand-Fenoel V; Sibon D; Frenzel L; Raphalen JH; Helias P; Renaudier P; Santa F; Lecuit M; Lortholary O; Hermine O; Aguilar C; Marçais A
Ann Hematol; 2021 Nov; 100(11):2813-2824. PubMed ID: 34387741
[TBL] [Abstract][Full Text] [Related]
18. Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de Linfoproliferativos.
Malpica L; Enriquez DJ; Castro DA; Peña C; Idrobo H; Fiad L; Prates M; Otero V; Biglione M; Altamirano M; Sandival-Ampuero G; Aviles-Perez U; Meza K; Aguirre-Martinez L; Cristaldo N; Maradei JL; Guanchiale L; Soto P; Viñuela JL; Cabrera ME; Paredes SR; Riva E; Di Stefano M; Noboa A; Choque JA; Candelaria M; Von Glasenapp A; Valvert F; Torres-Viera MA; Castillo JJ; Ramos JC; Villela L; Beltran BE
JCO Glob Oncol; 2021 Jul; 7():1151-1166. PubMed ID: 34270330
[TBL] [Abstract][Full Text] [Related]
19. Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.
Kchour G; Makhoul NJ; Mahmoudi M; Kooshyar MM; Shirdel A; Rastin M; Rafatpanah H; Tarhini M; Zalloua PA; Hermine O; Farid R; Bazarbachi A
Leuk Lymphoma; 2007 Feb; 48(2):330-6. PubMed ID: 17325893
[TBL] [Abstract][Full Text] [Related]
20. Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide.
Besson C; Panelatti G; Delaunay C; Gonin C; Brebion A; Hermine O; Plumelle Y
Leuk Lymphoma; 2002 Dec; 43(12):2275-9. PubMed ID: 12613513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
